News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis Corporation (NVS) Gets FDA Approvable Letter For Aclasta


2/27/2006 10:30:11 AM

ZURICH, Feb 27 (Reuters) - Swiss drug maker Novartis (NOVN.VX: Quote, Profile, Research) has received an "approvable letter" from U.S. drug regulators for its Aclasta drug for use in the treatment of Paget's disease, a painful bone disorder, the firm said.


Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES